# A "Window Trial" on Boswellia for Breast Cancer Primary Tumors

> **NCT03149081** · PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 46 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Boswellia

## Key facts

- **NCT ID:** NCT03149081
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-31
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-04-29
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03149081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03149081, "A "Window Trial" on Boswellia for Breast Cancer Primary Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03149081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*